Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor

(2017) Jorge Fuentealba et al.   Neural Regeneration Research

Early High-Dose Erythropoietin Therapy After Out-of-Hospital Cardiac Arrest

(2016) Alain Cariou et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

(2016) Karen Schreiber et al.   Multiple Sclerosis Journal

ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception

(2016) Wenjia Zhang et al.   PEPTIDES

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

(2016) Karen Schreiber et al.   Multiple Sclerosis Journal

Endogenous neural stem cell responses to stroke and spinal cord injury

(2015) Catherine-Alexandra Grégoire et al.   GLIA

Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP)

(2015) Davide Dalla Costa et al.   NEUROLOGICAL SCIENCES

ARA 290 for treatment of small fiber neuropathy in sarcoidosis

(2014) Monique van Velzen et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

ARA 290, a Peptide Derived from the Tertiary Structure of Erythropoietin, Produces Long-Term Relief of Neuropathic Pain Coupled with Suppression of the Spinal Microglia Response

(2014) Maarten Swartjes et al.   Molecular Pain

Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease

(2013) Wooyoung Jang et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Unknown

(2013) Lara Heij et al.   MOLECULAR MEDICINE

Randomized Trial of Short-Course High-Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients

(2012) Z. Aydin et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis

(2012) Kurt-Wolfram Sühs et al.   ANNALS OF NEUROLOGY

Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats

(2012) Ling Wei et al.   NEUROBIOLOGY OF DISEASE

Erythropoietin: still on the neuroprotection road

(2012) Nelvys Subirós et al.   Therapeutic Advances in Neurological Disorders

Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty

(2011) Melita Buljan et al.   INTERNATIONAL ORTHOPAEDICS

Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients

(2010) Kamilla W. Miskowiak et al.   PSYCHOPHARMACOLOGY

Erythropoietin in amyotrophic lateral sclerosis: A pilot, randomized, double-blind, placebo-controlled study of safety and tolerability

(2009) Giuseppe Lauria et al.   Amyotrophic Lateral Sclerosis

Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke

(2009) Hannelore Ehrenreich et al.   STROKE

In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain

(2008) Michelle Hedrick Theus et al.   EXPERIMENTAL NEUROLOGY

Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

(2008) Anna-Leena Sirén et al.   Neurotherapeutics